胃食管反流病内镜下治疗的方法与评价

张良; 吴继敏

doi:10.3969/j.issn.1671-038X.2023.07.06

胃食管反流病内镜下治疗的方法与评价

张良^1,2,
吴继敏^2,Δ, ,

- 1.
  锦州医科大学(辽宁锦州，121000)
- 2.
  解放军火箭军特色医学中心胃食管外科

详细信息

通讯作者: 吴继敏，E-mail：drjiminwu@126.com

^Δ审校者

中图分类号: R473.5

收稿日期: 2023-04-12

刊出日期: 2023-07-15

Methods and evaluation of the endoscopic treatment of gastroesophageal reflux disease

ZHANG Liang^1,2,
WU Jimin^2,Δ, ,

- 1.
  Jinzhou Medical University, Jinzhou, Liaoning, 121000, China
- 2.
  Department of Gastroesophageal Surgery, the Special Medical Center of the Chinese People's Liberation Army Rocket Army

More Information

Corresponding author: WU Jimin, E-mail: drjiminwu@126.com

Received Date: 12 April 2023

Publish Date: 15 July 2023

摘要

摘要: 胃食管反流病是一种临床上常见的消化系统疾病。在胃食管反流病的治疗方面，长时间内集中于药物治疗和腹腔镜胃底折叠术两种方式。随着近年来内镜技术的发展，出现了诸多创伤小、不良反应少的内镜新技术，例如：内镜下射频消融治疗、内镜下贲门黏膜缩窄术、内镜下胃底折叠术等。内镜治疗技术的兴起，对胃食管反流病的治疗方式进行了补充并提供了新的治疗选择。本文就内镜下胃食管反流病的治疗方法及其评价作一综述。
- 胃食管反流病 /
- 内镜术
Abstract: Gastroesophageal reflux disease is a clinically common digestive system disease. In the treatment of gastroesophageal reflux disease, it focuses on drug treatment and laparoscopic antireflux surgery for a long time. With the development of endoscopic technology in recent years, there have been many new endoscopic technologies with little trauma and low side effects, such as endoscopic radiofrequency ablation, endoscopic mucosal constriction of the cardia, endoscopic gastric fundus plication, etc. The rise of endoscopic therapy has supplemented and provided new treatment options for the treatment of gastroesophageal reflux disease. This review reviews the methods and their evaluation of endoscopic treatment.
- gastroesophageal reflux disease /
- endoscopy

HTML全文

参考文献(38)

[1]	中国医师协会外科医师分会胃食管反流病专业委员会. 胃食管反流病外科诊疗共识(2019版)[J]. 中华胃食管反流病电子杂志, 2019, 6(1): 3-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SDFL202101001.htm
[2]	罗璇. 胃食管反流病发病机制研究进展[J]. 微量元素与健康研究, 2015, 32(4): 60-61. https://www.cnki.com.cn/Article/CJFDTOTAL-WYJK201504035.htm
[3]	Spechler SJ. Evaluation and treatment of patients with persistent reflux symptoms despite proton pump inhibitor treatment[J]. Gastroenterol Clin North Am, 2020, 49(3): 437-450. doi: 10.1016/j.gtc.2020.04.003
[4]	Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4): 283-288. doi: 10.1097/SLE.0b013e3182582e92
[5]	Csendes A, Orellana O, Cuneo N, et al. Long-term(15-year)objective evaluation of 150 patients after laparoscopic Nissen fundoplication[J]. Surgery, 2019, 166(5): 886-894. doi: 10.1016/j.surg.2019.04.024
[6]	Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease[J]. Gastroenterol Rep(Oxf), 2015, 3(1): 41-53.
[7]	中国医疗保健国际交流促进会胃食管反流多学科分会. 中国胃食管反流病多学科诊疗共识[J]. 中国医学前沿杂志(电子版), 2019, 11(9): 30-56. https://www.cnki.com.cn/Article/CJFDTOTAL-SDFL202001002.htm
[8]	Franciosa M, Triadafilopoulos G, Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality[J]. Gastroenterol Res Pract, 2013, 2013: 783815.
[9]	Utley DS. The Stretta procedure: device, technique, and pre-clinical study data[J]. Gastrointest Endosc Clin N Am, 2003, 13(1): 135-145. doi: 10.1016/S1052-5157(02)00113-7
[10]	Viswanath Y, Maguire N, Dhar A, et al. PTH-040 Medium term outcomes of endoscopic stretta therapy in refractory GERD-single center 2-year follow up[J]. Gut, 2019, 68(Suppl 2): A32.
[11]	Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: a single-center prospective study[J]. J Dig Dis, 2019, 20(5): 229-234. doi: 10.1111/1751-2980.12722
[12]	Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc, 2014, 28(8): 2323-2333. doi: 10.1007/s00464-014-3461-6
[13]	Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882. doi: 10.1007/s00464-017-5431-2
[14]	Liang WT, Yan C, Wang ZG, et al. Early and midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational study[J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661. doi: 10.1089/lap.2015.0188
[15]	于雪梅. 经口内镜下贲门缩窄术治疗胃食管反流病的疗效及安全性研究[D]. 呼和浩特: 内蒙古医科大学, 2020.
[16]	Li ZT, Ji F, Han XW, et al. Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study[J]. Surg Endosc, 2021, 35(7): 4035-4041. doi: 10.1007/s00464-021-08397-y
[17]	Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease[J]. Medicine(Baltimore), 2018, 97(15): e0169.
[18]	张熠. 内镜下贲门缩窄术与腹腔镜Nissen胃底折叠术治疗胃食管反流病的效果对比[D]. 开封: 河南大学, 2020.
[19]	胡海清, 令狐恩强. 胃食管反流病内镜治疗现状[J]. 中华胃肠内镜电子杂志, 2017, 4(1): 36-40. doi: 10.3877/cma.j.issn.2095-7157.2017.01.010
[20]	Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: experience of 109 cases[J]. Dig Endosc, 2021, 33(3): 347-354. doi: 10.1111/den.13727
[21]	Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy(ARMS)for GERD: feasibility, safety, and technique(with video)[J]. J Gastrointest Surg, 2019, 23(6): 1274-1278. doi: 10.1007/s11605-019-04115-1
[22]	Wong HJ, Su B, Attaar M, et al. Anti-reflux mucosectomy(ARMS)results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication[J]. Surg Endosc, 2021, 35(12): 7174-7182. doi: 10.1007/s00464-020-08144-9
[23]	江文俊, 周丽雅. 胃食管反流病的内镜治疗[J]. 临床荟萃, 2017, 32(1): 22-27, 32. doi: 10.3969/j.issn.1004-583X.2017.01.006
[24]	Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler(MUSE^TM)for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229. doi: 10.1007/s00464-014-3731-3
[25]	Bell RCW, Freeman K, Heidrick R, et al. Transoral incisionless fundoplication demonstrates durability at up to 9-years[J]. Therap Adv Gastroenterol, 2021, 14: 17562848211004827.
[26]	Testoni PA, Testoni S, Mazzoleni G, et al. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes[J]. Endoscopy, 2020, 52(6): 469-473. doi: 10.1055/a-1124-3187
[27]	Peng LH, Wan R, Chen SL, et al. Efficacy of endoscopic anterior fundoplication with a novel ultrasonic surgical endostapler for gastroesophageal reflux disease: six-month results from a multicenter prospective trial[J]. Endosc Ultrasound, 2023, 12(1): 128-134. doi: 10.4103/EUS-D-21-00244
[28]	Ramai D, Shapiro A, Barakat M, et al. Adverse events associated with transoral incisionless fundoplication(TIF)for chronic gastroesophageal reflux disease: a MAUDE database analysis[J]. Surg Endosc, 2022, 36(7): 4956-4959. doi: 10.1007/s00464-021-08851-x
[29]	宗冠兆. 内镜下胃底折叠术治疗胃食管反流病的临床研究[D]. 上海: 上海交通大学, 2019.
[30]	Kalapala R, Karyampudi A, Nabi Z, et al. Tu1984 randomized sham controlled trial of endoscopic full thickness plication for the treatment of ppi dependant gerd[J]. Gastrointest Endosc, 2019, 89(6): AB643.
[31]	von Renteln D, Schmidt A, Riecken B, et al. Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease(GERD)with impedance monitoring[J]. Surg Endosc, 2010, 24(5): 1040-1048. doi: 10.1007/s00464-009-0723-9
[32]	Kaindlstorfer A, Koch OO, Antoniou SA, et al. A randomized trial on endoscopic full-thickness gastroplication versus laparoscopic antireflux surgery in GERD patients without hiatal hernias[J]. Surg Laparosc Endosc Percutan Tech, 2013, 23(2): 212-222. doi: 10.1097/SLE.0b013e3182827f79
[33]	Zagol B, Mikami D. Advances in transoral fundoplication for oesophageal reflux[J]. Dig Liver Dis, 2011, 43(5): 361-364. doi: 10.1016/j.dld.2011.01.006
[34]	Ozawa S, Kumai K, Higuchi K, et al. Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan[J]. J Gastroenterol, 2009, 44(7): 675-684. doi: 10.1007/s00535-009-0064-4
[35]	Schiefke I, Zabel-Langhennig A, Neumann S, et al. Long term failure of endoscopic gastroplication(EndoCinch)[J]. Gut, 2005, 54(6): 752-758. doi: 10.1136/gut.2004.058354
[36]	Hogan WJ. Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures?[J]. Am J Gastroenterol, 2006, 101(3): 437-439. doi: 10.1111/j.1572-0241.2006.00523.x
[37]	Mason RJ, Hughes M, Lehman GA, et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer(Enteryx)in a porcine model[J]. Surg Endosc, 2002, 16(3): 386-391. doi: 10.1007/s004640080189
[38]	Kamler JP, Lemperle G, Lemperle S, et al. Endoscopic lower esophageal sphincter bulking for the treatment of GERD: safety evaluation of injectable polymethylmethacrylate microspheres in miniature swine[J]. Gastrointest Endosc, 2010, 72(2): 337-342.